Clinical outcomes of subcutaneous vs. transvenous implantable defibrillator therapy in a polymorbid patient cohort

BACKGROUND: The subcutaneous implantable cardioverter-defibrillator (S-ICD) has been designed to overcome lead-related complications and device endocarditis. Lacking the ability for pacing or resynchronization therapy its usage is limited to selected patients at risk for sudden cardiac death (SCD)....

Descripción completa

Detalles Bibliográficos
Autores principales: Kattih, Badder, Operhalski, Felix, Boeckling, Felicitas, Hecker, Florian, Michael, Felix, Vamos, Mate, Hohnloser, Stefan H., Erath, Julia W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624387/
https://www.ncbi.nlm.nih.gov/pubmed/36330004
http://dx.doi.org/10.3389/fcvm.2022.1008311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624387/
https://www.ncbi.nlm.nih.gov/pubmed/36330004
http://dx.doi.org/10.3389/fcvm.2022.1008311

Ejemplares similares